The other two, MCP-1 and MIP-1alpha, have previously been shown to exhibit increased levels following a TBI event, although in the present study they failed to accurately distinguish between CT-positive and CT-negative mTBI patients.[25–29,42] Other markers among the 92 tested could also be of interest as TBI biomarkers. This evidence concerns the gene CCL2 and concussion.